MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
MEGIN Installs the First MEG Maps™ Enabled TRIUX™ neo in Japan

MEGIN Installs the First MEG Maps™ Enabled TRIUX™ neo in Japan

by Naomi Devlin | Apr 27, 2026 | MEGIN News

MEGIN Installs the First MEG Maps™ Enabled TRIUX™ neo at the National Institute for Minamata Disease by MEGIN | April 30, 2026 | MEGIN news HELSINKI, FINLAND. April 30, 2026 – MEGIN, the global leader in magnetoencephalography (MEG) solutions, has installed a MEG...
Inside the Brain: How Hearing Differences Shape Learning | Boys Town Research

Inside the Brain: How Hearing Differences Shape Learning | Boys Town Research

by Naomi Devlin | Apr 27, 2026 | MEGIN News

Cutting-Edge Research Advances Understanding of Parkinson’s Treatment at SFU

Cutting-Edge Research Advances Understanding of Parkinson’s Treatment at SFU

by Naomi Devlin | Apr 23, 2026 | MEGIN News

MEGIN Matters April 2026

MEGIN Matters April 2026

by Naomi Devlin | Apr 13, 2026 | MEGIN News

MEGIN Announces New Distributor Partnership with Aerobe in India 

MEGIN Announces New Distributor Partnership with Aerobe in India 

by Naomi Devlin | Mar 13, 2026 | MEGIN News

MEGIN announces New Distributor Partnership with Aerobe in India by MEGIN | March 13, 2026 | MEGIN news HELSINKI, FINLAND. March 13, 2026 – MEGIN, a global leader in functional neuroimaging and magnetoencephalography (MEG) solutions, is pleased to announce a new...
« Older Entries
Next Entries »

Home
About us
MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.